Phenotype and suppressor activity of T-lymphocyte clones extracted from lesions of oral lichen planus. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Phenotype and suppressor activity of T-lymphocyte clones extracted from lesions of oral lichen planus.

Br J Dermatol. 1994 Sep;131(3):319-24. Unique Identifier : AIDSLINE MED/95001448
Sugerman PB; Savage NW; Seymour GJ; Department of Dentistry, University of Queensland, St Lucia,; Australia.


Abstract: Lymphocytes were extracted from six biopsy specimens of oral lichen planus. T-lymphocyte lines were expanded in culture with phytohaemagglutinin and interleukin 2, and cloned by limiting dilution. Fifteen T-cell clones were isolated with a probability of clonality of 96.3%. The majority of clones (n = 13) expressed the alpha beta T-cell receptor, and of these, 11 were CD8+ and two were CD4+. Two clones were CD4- and CD8-, and expressed the gamma delta T-cell receptor. The ability of these clones (effectors) to suppress concanavalin-A-stimulated proliferation of autologous lesional T-cell lines (responders) was assessed. Maximum suppressor activity ranged from 17 to 100%. The majority of clones (n = 12), including a CD3+ CD4+ CD8-alpha beta+ clone, displayed suppressor activity which was proportional to the effector to responder ratio. A CD3+CD4+CD8-alpha beta+ clone and a CD3+CD4-CD8-gamma delta+ clone displayed substantial helper activity at higher effector to responder ratios. These results demonstrate differential helper and suppressor activity of T-lymphocyte clones extracted from oral lichen planus lesions. The balance between help and suppression may be a fundamental determinant of immunological activity within the lymphocytic infiltrate of oral lichen planus, and hence may dictate the clinical behaviour of the disease.
Keywords: Adult Aged CD4-Positive T-Lymphocytes/CHEMISTRY/*IMMUNOLOGY CD8-Positive T-Lymphocytes/CHEMISTRY/*IMMUNOLOGY Female Human Lichen Planus, Oral/*IMMUNOLOGY Lymphocyte Transformation/IMMUNOLOGY Middle Age Phenotype Receptors, Antigen, T-Cell, alpha-beta/ANALYSIS Receptors, Antigen, T-Cell, gamma-delta/ANALYSIS Support, Non-U.S. Gov't T-Lymphocytes, Helper-Inducer/IMMUNOLOGY JOURNAL ARTICLEKWDadultagedcd4-positivet-lymphocytes/chemistry/KWDimmunologycd8-positivet-lymphocytes/chemistry/KWDimmunologyfemalehumanlichenplanus,oral/KWDimmunologylymphocytetransformation/immunologymiddleagephenotypereceptors,antigen,t-cell,alpha-beta/analysisreceptors,antigen,t-cell,gamma-delta/analysissupport,non-uKWDsKWDgov'tt-lymphocytes,helper-inducer/immunologyjournalarticle
950130
M9510816

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .